Researchers found that blood tests measuring glycans could offer early insights into chronic inflammation, a condition linked to aging and various diseases. GlycanAge, a company specializing in this field, will host a conference in Dubrovnik, Croatia, starting June 19, to mark 25 years of research on “inflammaging.” This event, co-organized with the Mayo Clinic, will feature leading academics and clinicians discussing how glycan-based markers can be integrated into routine health assessments.

For those interested in healthy aging, this research could be significant. Glycan patterns in the blood can indicate whether your immune response is leaning towards inflammation, which is associated with conditions like diabetes, heart attacks, and strokes. The ability to detect these changes up to ten years before diseases manifest means that you could potentially take preventive measures to improve your health. GlycanAge’s test has shown a high level of accuracy, with a reported measurement error of less than one year.

The conference will focus on advancing the use of glycan testing in clinical settings, but it’s important to note that this research is still evolving. While GlycanAge has analyzed over 300,000 individuals and contributed to more than 350 peer-reviewed studies, the widespread adoption of glycan testing in everyday healthcare is still in its early stages. As this field develops, it could become a valuable tool for monitoring health and preventing age-related diseases.

Source: longevity.technology